Amyloid-beta42 signals tau hyperphosphorylation and compromises neuronal viability by disrupting alkylacylglycerophosphocholine metabolism.

Proceedings of the National Academy of Sciences of the United States of America
Scott D RyanSteffany A L Bennett

Abstract

Perturbation of lipid second messenger networks is associated with the impairment of synaptic function in Alzheimer disease. Underlying molecular mechanisms are unclear. Here, we used an unbiased lipidomic approach to profile alkylacylglycerophosphocholine second messengers in diseased tissue. We found that specific isoforms defined by a palmitic acid (16:0) at the sn-1 position, namely 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine (C16:0 PAF) and 1-O-hexadecyl-sn-glycero-3-phosphocholine (C16:0 lyso-PAF), were elevated in the temporal cortex of Alzheimer disease patients, transgenic mice expressing human familial disease-mutant amyloid precursor protein, and human neurons directly exposed to amyloid-beta(42) oligomers. Acute intraneuronal accumulation of C16:0 PAF but not C16:0 lyso-PAF initiated cyclin-dependent kinase 5-mediated hyperphosphorylation of tau on Alzheimer disease-specific epitopes. Chronic elevation caused a caspase 2 and 3/7-dependent cascade resulting in neuronal death. Pharmacological inhibition of C16:0 PAF signaling, or molecular strategies increasing hydrolysis of C16:0 PAF to C16:0 lyso-PAF, protected human neurons from amyloid-beta(42) toxicity. Together, these data provide mechanistic insight into...Continue Reading

References

May 23, 1995·Proceedings of the National Academy of Sciences of the United States of America·I IzquierdoN G Bazan
Jun 11, 2002·Biochemical and Biophysical Research Communications·Heinz FischerErwin Tschachler
Jun 12, 2003·Behavioural Brain Research·Manish Kumar SarafManjeet Singh
Oct 1, 2004·The Journal of Biological Chemistry·Fanny BoninSteffany A L Bennett
Oct 16, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Badreddine KriemThierry Pillot
Apr 28, 2006·Neuroreport·SeungYong YoonDongHou Kim
May 20, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Nathan J D McLaughlinChristopher C Silliman
Sep 12, 2006·Biochimica Et Biophysica Acta·Yoshihiro KitaTakao Shimizu
Jan 25, 2007·Nature Reviews. Molecular Cell Biology·Christian Haass, Dennis J Selkoe
Jun 16, 2007·The Journal of Biological Chemistry·Paloma Goñi-OliverFélix Hernández
Nov 14, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Omidreza FiruziDomenico Praticò
Feb 21, 2008·The Journal of Biological Chemistry·Takeshi HarayamaTakao Shimizu
Aug 20, 2008·The Journal of Cell Biology·Sungmin SongYong-Keun Jung
Aug 23, 2008·The Journal of Biological Chemistry·Hideo Shindou, Takao Shimizu
Oct 22, 2008·Nature Neuroscience·Rene O Sanchez-MejiaLennart Mucke

❮ Previous
Next ❯

Citations

Sep 29, 2011·Apoptosis : an International Journal on Programmed Cell Death·Jack H Jhamandas, David Mactavish
Sep 24, 2010·Nature Reviews. Molecular Cell Biology·Marisa R Buchakjian, Sally Kornbluth
Mar 31, 2011·Nature Reviews. Neuroscience·Gilbert Di Paolo, Tae-Wan Kim
Jun 10, 2010·The Journal of Biological Chemistry·Leigh Anne SwayneSteffany A L Bennett
Dec 3, 2011·The Journal of Biological Chemistry·Robin B ChanGilbert Di Paolo
Apr 16, 2014·Neuroscience Bulletin·Qiang Liu, Juan Zhang
Sep 10, 2014·Journal of Diabetes Research·Jian-Qin WangYu-Hong Jing
Jul 25, 2015·Toxicological Sciences : an Official Journal of the Society of Toxicology·Fang LiuXianlin Han
Apr 20, 2012·Expert Opinion on Therapeutic Patents·Gary Probst, Ying-zi Xu
Jan 14, 2016·Scientific Reports·Michael A KennedyKristin Baetz
Mar 9, 2017·Journal of Alzheimer's Disease : JAD·Francis T HaneMitchell S Albert
Feb 23, 2017·Journal of Alzheimer's Disease : JAD·Francis T HaneZoya Leonenko
Feb 27, 2018·Journal of Alzheimer's Disease : JAD·Fabian DorningerJohannes Berger
Mar 29, 2018·Journal of Cell Science·Craig OsborneClive Bate
Jun 9, 2018·The Journal of Biological Chemistry·Shayne A SniderMorgan D Fullerton
Jun 1, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Laura SchnöderYang Liu
Nov 22, 2012·Journal of Cellular Physiology·Ivana SirangeloMaria Luisa Balestrieri
Dec 15, 2017·Journal of Experimental Neuroscience·Clive Bate
Feb 29, 2020·Scientific Reports·Katherine PhanWoojin Scott Kim
Jun 1, 2017·Frontiers in Neuroscience·Rachel E LackieMarco A M Prado
Dec 12, 2020·The Journal of Pharmacology and Experimental Therapeutics·Nidhi ShardaKarunya K Kandimalla
Feb 26, 2021·Cell Communication and Signaling : CCS·Smita Eknath Desale, Subashchandrabose Chinnathambi
Aug 31, 2020·Neurobiology of Disease·Fabian DorningerJohannes Berger
Sep 14, 2010·Bioorganic & Medicinal Chemistry Letters·Anh P TruongJohn-Michael Sauer
Sep 21, 2010·Journal of Molecular Biology·Kirsten DahseAlfred Fahr
Jan 13, 2011·The American Journal of Pathology·Jack H JhamandasDavid MacTavish

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.